Medical education company Simbionix is looking to become the industry leader in what could be the next generation of surgical simulation technology: patient-specific simulation.
Patient-specific simulation refers to importing scans of a particular patient’s body, such as CTAs, into a simulator to allow a doctor to rehearse a near-exact replica of the operation he’ll conduct the following day, for example.
Health Executives on Digital Transformation in Healthcare
Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare.
The advantage to a simulation company like Simbionix of patient-specific surgery is that it opens up a market of experienced surgeons who could become customers.
“Patient-specific simulation potentially opens up a new market for us within the clinical environment, whether with experienced surgeons or residents and fellows learning new procedures,” said Simbionix CEO Gary Zamler. “It also allows us to interact with the larger imaging and medical device companies.”
Because patient-specific simulation may become a hot market, Israel- and Cleveland-based Simbionix is far from the only player. Competitors include Surgical Science and Immersive Touch. Simbionix even has a local, Cleveland-area competitor in the space, Surgical Theater.
Simbionix has already made substantial progress in the market. Its patient-specific product called the PROcedure Rehersal Studio has received U.S. Food and Drug Administration clearance for two applications: carotid stenting and endovascular aneurysm repair.
The Funding Model for Cancer Innovation is Broken — We Can Fix It
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
In its history, Simbionix has placed about 1,400 simulators in 40 countries. The 100-employee company, which was founded in Israel and established its U.S. headquarters in Cleveland, gets about 60 percent of its business from teaching hospitals and simulation centers, with the remainder coming from medical technology companies, Zamler said.
In the video below, Simbionix’s Virginia Budzinski demonstrates a procedure to treat an abdominal aortic aneurysm on the company’s PROcedure Rehearsal Studio simulator.